HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

DCGO

DocGo Inc. (NASDAQ)

Healthcare — Medical Care Facilities

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

None 4 analysts
$0.55
+$0.03 (+6.01%)
Target: $1.88 (242.8%)
Sign in to add DCGO to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$54.03M
P/E Ratio (TTM)-
Forward P/E10.75
EPS (TTM)$-1.90
Dividend Yield-
Profit Margin-62.23%
Revenue Growth-21.30%
ROE-97.78%
Debt/Equity25.63
Recommendation None
Analyst Target$1.88
Analysts4
Indexes NASDAQ

Technical Indicators

RSI (14)48.2
Beta1.00
SMA 20-
SMA 40-
52-Week High$1.78
52-Week Low$0.45
50-Day Avg$0.60
200-Day Avg$0.85
Avg Volume980.0K
Volume616.1K

Performance Analysis

NEUTRAL

DCGO presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($0.45), which could present a value opportunity.
~ RSI at 48.2 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- Revenue declined 21.3% year-over-year.
- Operating at a loss with -62.2% margin.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $1.88 implies 242.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:05 UTC

Back to Screener Export Report